wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28075683-104D4D5B-47D4-45D2-A973-FEBBD6859C87
Q28075683-104D4D5B-47D4-45D2-A973-FEBBD6859C87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075683-104D4D5B-47D4-45D2-A973-FEBBD6859C87
The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemia
P2860
Q28075683-104D4D5B-47D4-45D2-A973-FEBBD6859C87
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075683-104D4D5B-47D4-45D2-A973-FEBBD6859C87
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae7ae7569a49164153c55e6f2640a27ab0ff1284
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies